Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management
Identifieur interne : 002534 ( Main/Exploration ); précédent : 002533; suivant : 002535Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management
Auteurs : Doug Hacking ; Rosalind Smyth ; Nigel Shaw ; George Kokia ; Helen Carty ; David HeafSource :
- Archives of Disease in Childhood [ 0003-9888 ] ; 2000-08-01.
Descripteurs français
- KwdFr :
- Agents de l'appareil respiratoire (usage thérapeutique), Anti-inflammatoires (usage thérapeutique), Biopsie, Femelle, Fibrose pulmonaire (), Fibrose pulmonaire (anatomopathologie), Fibrose pulmonaire (diagnostic), Humains, Hydroxychloroquine (usage thérapeutique), Mâle, Nourrisson, Nouveau-né, Oxygénothérapie (), Poumon (anatomopathologie), Prednisolone (usage thérapeutique), Pronostic, Survivants, Tomodensitométrie, Études rétrospectives.
- MESH :
- anatomopathologie : Fibrose pulmonaire, Poumon.
- diagnostic : Fibrose pulmonaire.
- usage thérapeutique : Agents de l'appareil respiratoire, Anti-inflammatoires, Hydroxychloroquine, Prednisolone.
- Pascal (Inist)
- MESH :
- Wicri :
- topic : Enfant.
English descriptors
- KwdEn :
- Anti-Inflammatory Agents (therapeutic use), Antiinflammatory agent, Biopsy, Case study, Chemotherapy, Child, Corticosteroid, Female, Hamman Rich interstitial pulmonary fibrosis, Humans, Hydroxychloroquine (therapeutic use), Idiopathic, Immunosuppressive agent, Infant, Infant, Newborn, Long term, Lung (pathology), Male, Oxygen Inhalation Therapy (methods), Prednisolone, Prednisolone (therapeutic use), Prognosis, Pulmonary Fibrosis (diagnosis), Pulmonary Fibrosis (pathology), Pulmonary Fibrosis (therapy), Respiratory System Agents (therapeutic use), Retrospective Studies, Survivors, Tomography, X-Ray Computed, Treatment.
- MESH :
- chemical , therapeutic use : Anti-Inflammatory Agents, Hydroxychloroquine, Prednisolone, Respiratory System Agents.
- diagnosis : Pulmonary Fibrosis.
- methods : Oxygen Inhalation Therapy.
- pathology : Lung, Pulmonary Fibrosis.
- therapy : Pulmonary Fibrosis.
- Teeft :
- Alveolar septa, Alveolitis, Avected children, Biopsy, Biopsy sample, Biopsy samples, Bronchoalveolar lavage, Brosing, Brosing alveolitis, Brosis, Case series, Centile, Centile height, Centile prednisolone, Centile prednisolone trial, Centile weight, Chest radiographs, Clinical presentation, Desquamative, European society, Family history, Female, Fibrosing alveolitis, General anaesthesia, Good prognosis, Good response, Histological, Histological analysis, Home oxygen, Home oxygen exercise limitation, Humans, Idiopathic, Infant, Infant, Newborn, Insuycient lung tissue, Interstitial, Interstitial disease, Interstitial lung, Interstitial lung disease, Interstitial shadowing, Lung biopsy, Lung disease, Lung function, Lymphocyte, Macrophage, Male, Median, Median time, Months exercise limitation, Months years, Natural history, Nocturnal oxygen, Oral prednisolone, Oral steroids, Patient group, Pediatr, Pediatr pulmonol, Percutaneous, Percutaneous lung biopsy, Pneumonitis, Polymorphonuclear cells, Poor prognosis, Prednisolone, Previous reports, Prognosis, Pulmonary hypertension, Rapid responses, Respiratory symptoms, Retrospective Studies, Royal liverpool, Small numbers, Steroid, Steroid response, Survivors, Symptom, Tissue samples, Tomography, X-Ray Computed, Vital capacity, Weight gain, Year period, Years birth.
Abstract
BACKGROUND Pulmonary interstitial fibrosis in children is a disease of unknown aetiology, usually associated with a poor prognosis. METHODS In this case series we describe 11 children presenting over a 10 year period, managed conservatively and associated with a good prognosis. RESULTS In six, symptoms were present from birth and 10 had symptoms at or before 3 months. Diagnosis was made using chest computed tomography and percutaneous lung biopsy. All patients were treated with oral prednisolone. In five no steroid response was noted. One patient responded to hydroxychloroquine. Home oxygen was required in five patients. At follow up all patients are alive at a median age of 6 years (range 1 to 12 years). The two recently diagnosed children have significant symptoms, seven have dyspnoea on exercise, and two are symptom free. CONCLUSION The good prognosis seen in these patients is different to previous case reports, indicating a greater than 50% mortality.
Url:
DOI: 10.1136/adc.83.2.152
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000E55
- to stream Istex, to step Curation: 000E55
- to stream Istex, to step Checkpoint: 001352
- to stream PubMed, to step Corpus: 000485
- to stream PubMed, to step Curation: 000485
- to stream PubMed, to step Checkpoint: 000457
- to stream Ncbi, to step Merge: 000010
- to stream Ncbi, to step Curation: 000010
- to stream Ncbi, to step Checkpoint: 000010
- to stream Main, to step Merge: 002562
- to stream PascalFrancis, to step Corpus: 000062
- to stream PascalFrancis, to step Curation: 000004
- to stream PascalFrancis, to step Checkpoint: 000062
- to stream Main, to step Merge: 002616
- to stream Main, to step Curation: 002534
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management</title>
<author><name sortKey="Hacking, Doug" sort="Hacking, Doug" uniqKey="Hacking D" first="Doug" last="Hacking">Doug Hacking</name>
</author>
<author><name sortKey="Smyth, Rosalind" sort="Smyth, Rosalind" uniqKey="Smyth R" first="Rosalind" last="Smyth">Rosalind Smyth</name>
</author>
<author><name sortKey="Shaw, Nigel" sort="Shaw, Nigel" uniqKey="Shaw N" first="Nigel" last="Shaw">Nigel Shaw</name>
</author>
<author><name sortKey="Kokia, George" sort="Kokia, George" uniqKey="Kokia G" first="George" last="Kokia">George Kokia</name>
</author>
<author><name sortKey="Carty, Helen" sort="Carty, Helen" uniqKey="Carty H" first="Helen" last="Carty">Helen Carty</name>
</author>
<author><name sortKey="Heaf, David" sort="Heaf, David" uniqKey="Heaf D" first="David" last="Heaf">David Heaf</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:11414948524DFA482F0F59D1D70E141CEAB5AD47</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1136/adc.83.2.152</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-J1C4FN7H-Z/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000E55</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E55</idno>
<idno type="wicri:Area/Istex/Curation">000E55</idno>
<idno type="wicri:Area/Istex/Checkpoint">001352</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001352</idno>
<idno type="wicri:doubleKey">0003-9888:2000:Hacking D:idiopathic:pulmonary:fibrosis</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10906025</idno>
<idno type="wicri:Area/PubMed/Corpus">000485</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000485</idno>
<idno type="wicri:Area/PubMed/Curation">000485</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000485</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000457</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000457</idno>
<idno type="wicri:Area/Ncbi/Merge">000010</idno>
<idno type="wicri:Area/Ncbi/Curation">000010</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000010</idno>
<idno type="wicri:Area/Main/Merge">002562</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:00-0386276</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000062</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000004</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000062</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000062</idno>
<idno type="wicri:doubleKey">0003-9888:2000:Hacking D:idiopathic:pulmonary:fibrosis</idno>
<idno type="wicri:Area/Main/Merge">002616</idno>
<idno type="wicri:Area/Main/Curation">002534</idno>
<idno type="wicri:Area/Main/Exploration">002534</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management</title>
<author><name sortKey="Hacking, Doug" sort="Hacking, Doug" uniqKey="Hacking D" first="Doug" last="Hacking">Doug Hacking</name>
<affiliation><wicri:noCountry code="syntax">???</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Smyth, Rosalind" sort="Smyth, Rosalind" uniqKey="Smyth R" first="Rosalind" last="Smyth">Rosalind Smyth</name>
<affiliation><wicri:noCountry code="syntax">???</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Shaw, Nigel" sort="Shaw, Nigel" uniqKey="Shaw N" first="Nigel" last="Shaw">Nigel Shaw</name>
<affiliation><wicri:noCountry code="syntax">???</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Kokia, George" sort="Kokia, George" uniqKey="Kokia G" first="George" last="Kokia">George Kokia</name>
<affiliation><wicri:noCountry code="syntax">???</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Carty, Helen" sort="Carty, Helen" uniqKey="Carty H" first="Helen" last="Carty">Helen Carty</name>
<affiliation><wicri:noCountry code="syntax">???</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Heaf, David" sort="Heaf, David" uniqKey="Heaf D" first="David" last="Heaf">David Heaf</name>
<affiliation><wicri:noCountry code="syntax">???</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Archives of Disease in Childhood</title>
<title level="j" type="abbrev">Arch Dis Child</title>
<idno type="ISSN">0003-9888</idno>
<idno type="eISSN">1468-2044</idno>
<imprint><publisher>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</publisher>
<date type="published" when="2000-08-01">2000-08-01</date>
<biblScope unit="volume">83</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="152">152</biblScope>
</imprint>
<idno type="ISSN">0003-9888</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0003-9888</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Inflammatory Agents (therapeutic use)</term>
<term>Antiinflammatory agent</term>
<term>Biopsy</term>
<term>Case study</term>
<term>Chemotherapy</term>
<term>Child</term>
<term>Corticosteroid</term>
<term>Female</term>
<term>Hamman Rich interstitial pulmonary fibrosis</term>
<term>Humans</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Idiopathic</term>
<term>Immunosuppressive agent</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Long term</term>
<term>Lung (pathology)</term>
<term>Male</term>
<term>Oxygen Inhalation Therapy (methods)</term>
<term>Prednisolone</term>
<term>Prednisolone (therapeutic use)</term>
<term>Prognosis</term>
<term>Pulmonary Fibrosis (diagnosis)</term>
<term>Pulmonary Fibrosis (pathology)</term>
<term>Pulmonary Fibrosis (therapy)</term>
<term>Respiratory System Agents (therapeutic use)</term>
<term>Retrospective Studies</term>
<term>Survivors</term>
<term>Tomography, X-Ray Computed</term>
<term>Treatment</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Agents de l'appareil respiratoire (usage thérapeutique)</term>
<term>Anti-inflammatoires (usage thérapeutique)</term>
<term>Biopsie</term>
<term>Femelle</term>
<term>Fibrose pulmonaire ()</term>
<term>Fibrose pulmonaire (anatomopathologie)</term>
<term>Fibrose pulmonaire (diagnostic)</term>
<term>Humains</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Oxygénothérapie ()</term>
<term>Poumon (anatomopathologie)</term>
<term>Prednisolone (usage thérapeutique)</term>
<term>Pronostic</term>
<term>Survivants</term>
<term>Tomodensitométrie</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents</term>
<term>Hydroxychloroquine</term>
<term>Prednisolone</term>
<term>Respiratory System Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Fibrose pulmonaire</term>
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Pulmonary Fibrosis</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Fibrose pulmonaire</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Oxygen Inhalation Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lung</term>
<term>Pulmonary Fibrosis</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Pulmonary Fibrosis</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents de l'appareil respiratoire</term>
<term>Anti-inflammatoires</term>
<term>Hydroxychloroquine</term>
<term>Prednisolone</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antiinflammatoire</term>
<term>Chimiothérapie</term>
<term>Corticostéroïde</term>
<term>Enfant</term>
<term>Etude cas</term>
<term>Fibrose diffuse interstitielle poumon Hamman Rich</term>
<term>Idiopathique</term>
<term>Immunodépresseur</term>
<term>Long terme</term>
<term>Nourrisson</term>
<term>Prednisolone</term>
<term>Pronostic</term>
<term>Traitement</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Alveolar septa</term>
<term>Alveolitis</term>
<term>Avected children</term>
<term>Biopsy</term>
<term>Biopsy sample</term>
<term>Biopsy samples</term>
<term>Bronchoalveolar lavage</term>
<term>Brosing</term>
<term>Brosing alveolitis</term>
<term>Brosis</term>
<term>Case series</term>
<term>Centile</term>
<term>Centile height</term>
<term>Centile prednisolone</term>
<term>Centile prednisolone trial</term>
<term>Centile weight</term>
<term>Chest radiographs</term>
<term>Clinical presentation</term>
<term>Desquamative</term>
<term>European society</term>
<term>Family history</term>
<term>Female</term>
<term>Fibrosing alveolitis</term>
<term>General anaesthesia</term>
<term>Good prognosis</term>
<term>Good response</term>
<term>Histological</term>
<term>Histological analysis</term>
<term>Home oxygen</term>
<term>Home oxygen exercise limitation</term>
<term>Humans</term>
<term>Idiopathic</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Insuycient lung tissue</term>
<term>Interstitial</term>
<term>Interstitial disease</term>
<term>Interstitial lung</term>
<term>Interstitial lung disease</term>
<term>Interstitial shadowing</term>
<term>Lung biopsy</term>
<term>Lung disease</term>
<term>Lung function</term>
<term>Lymphocyte</term>
<term>Macrophage</term>
<term>Male</term>
<term>Median</term>
<term>Median time</term>
<term>Months exercise limitation</term>
<term>Months years</term>
<term>Natural history</term>
<term>Nocturnal oxygen</term>
<term>Oral prednisolone</term>
<term>Oral steroids</term>
<term>Patient group</term>
<term>Pediatr</term>
<term>Pediatr pulmonol</term>
<term>Percutaneous</term>
<term>Percutaneous lung biopsy</term>
<term>Pneumonitis</term>
<term>Polymorphonuclear cells</term>
<term>Poor prognosis</term>
<term>Prednisolone</term>
<term>Previous reports</term>
<term>Prognosis</term>
<term>Pulmonary hypertension</term>
<term>Rapid responses</term>
<term>Respiratory symptoms</term>
<term>Retrospective Studies</term>
<term>Royal liverpool</term>
<term>Small numbers</term>
<term>Steroid</term>
<term>Steroid response</term>
<term>Survivors</term>
<term>Symptom</term>
<term>Tissue samples</term>
<term>Tomography, X-Ray Computed</term>
<term>Vital capacity</term>
<term>Weight gain</term>
<term>Year period</term>
<term>Years birth</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Biopsie</term>
<term>Femelle</term>
<term>Fibrose pulmonaire</term>
<term>Humains</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Oxygénothérapie</term>
<term>Pronostic</term>
<term>Survivants</term>
<term>Tomodensitométrie</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Enfant</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">BACKGROUND Pulmonary interstitial fibrosis in children is a disease of unknown aetiology, usually associated with a poor prognosis. METHODS In this case series we describe 11 children presenting over a 10 year period, managed conservatively and associated with a good prognosis. RESULTS In six, symptoms were present from birth and 10 had symptoms at or before 3 months. Diagnosis was made using chest computed tomography and percutaneous lung biopsy. All patients were treated with oral prednisolone. In five no steroid response was noted. One patient responded to hydroxychloroquine. Home oxygen was required in five patients. At follow up all patients are alive at a median age of 6 years (range 1 to 12 years). The two recently diagnosed children have significant symptoms, seven have dyspnoea on exercise, and two are symptom free. CONCLUSION The good prognosis seen in these patients is different to previous case reports, indicating a greater than 50% mortality.</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Carty, Helen" sort="Carty, Helen" uniqKey="Carty H" first="Helen" last="Carty">Helen Carty</name>
<name sortKey="Hacking, Doug" sort="Hacking, Doug" uniqKey="Hacking D" first="Doug" last="Hacking">Doug Hacking</name>
<name sortKey="Heaf, David" sort="Heaf, David" uniqKey="Heaf D" first="David" last="Heaf">David Heaf</name>
<name sortKey="Kokia, George" sort="Kokia, George" uniqKey="Kokia G" first="George" last="Kokia">George Kokia</name>
<name sortKey="Shaw, Nigel" sort="Shaw, Nigel" uniqKey="Shaw N" first="Nigel" last="Shaw">Nigel Shaw</name>
<name sortKey="Smyth, Rosalind" sort="Smyth, Rosalind" uniqKey="Smyth R" first="Rosalind" last="Smyth">Rosalind Smyth</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002534 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002534 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:11414948524DFA482F0F59D1D70E141CEAB5AD47 |texte= Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management }}
This area was generated with Dilib version V0.6.33. |